Net Income

Glean's new research institute and context-aware agents offer a pragmatic path for businesses struggling to operationalize AI safely and effectively.

As drone attacks paralyze European airports, an Israeli tech firm's 'soft kill' net system emerges as a key contender for NATO's defense strategy.

Ally Financial's massive share repurchase isn't just a financial move. It’s a sign of fintech maturity and a confident bet on its own future.

Commercial Metals Company's fourth responsibility award isn't just PR. We decode how its deep ESG integration is a strategic moat in a changing market.

Professor Youmin Xi's recent honor signals more than academic success. It marks a strategic blueprint for cultivating the next generation of life science leaders.

Husqvarna unveils a massive cost-cutting plan alongside ambitious growth and green targets. Can this strategic pivot secure its future market leadership?

Hexagon Purus erases a $12.9M debt in its Panasonic battery deal but gives up lucrative US tax credits, a move securing its supply chain at a high cost.

A Chinese biotech is pioneering next-gen cancer drugs that promise higher precision and fewer side effects. Is this the future of oncology treatment?

Denali Therapeutics raises $200M to advance its brain-penetrating drugs, betting big on its pipeline despite short-term market jitters.

Following stellar clinical data, Terns Pharmaceuticals' upsized $650M offering signals massive investor confidence and funds its push to disrupt the CML market.

Bison's Meadowbrook is the first Alberta carbon hub to start operations, a pivotal moment for industrial decarbonization and the province's energy future.

Gossamer Bio's recent 200,000-share grant to a new hire is more than a welcome bonus; it's a strategic bet on its blockbuster drug candidate.

After a 94% stock collapse, 707 Cayman asks shareholders to approve a risky financing deal. Is this a necessary move for survival or a costly dilution?

A prestigious Yale recognition for board member Dr. Curtis Patton bolsters Tevogen's credibility as it advances its AI and T-cell platforms.

A new report shows a startling drop in dental benefits, revealing deep cracks in America's health system and new economic pressures on employers.

A California fragrance brand conquered Korea and now targets the U.S. We dissect the data-driven strategy and AI's quiet role in its rapid rise.

Abundia Global Impact Group and Alterra Energy are building a major plastics-to-fuel facility, a bold move to reshape the Gulf Coast's energy landscape.

A newly validated 'longevity protein' is fueling a biotech gold rush, but can companies turn breakthrough science into viable medicine? An inside look.

A $170M deal to boost infant formula supply has soured for Perrigo, leading to a 25% stock crash, a strategic review, and securities fraud lawsuits.

A regulatory filing from Weiss Asset Management reveals a complex arbitrage play on Alphawave IP, spotlighting its critical role in the Qualcomm deal.